These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30709382)

  • 1. Analysis on GENIE reveals novel recurrent variants that affect molecular diagnosis of sizable number of cancer patients.
    Koyama T; Rhrissorrakrai K; Parida L
    BMC Cancer; 2019 Feb; 19(1):114. PubMed ID: 30709382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AACR Project GENIE: Powering Precision Medicine through an International Consortium.
    AACR Project GENIE Consortium
    Cancer Discov; 2017 Aug; 7(8):818-831. PubMed ID: 28572459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GENIE Is Out of the Bottle: Landmark Cancer Genomics Dataset Released.
    Litchfield K; Turajlic S; Swanton C
    Cancer Discov; 2017 Aug; 7(8):796-798. PubMed ID: 28765114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.
    Kobayashi Y; Yang S; Nykamp K; Garcia J; Lincoln SE; Topper SE
    Genome Med; 2017 Feb; 9(1):13. PubMed ID: 28166811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AACR releases large cancer genomic data set from project GENIE.
    Printz C
    Cancer; 2017 May; 123(10):1685. PubMed ID: 28475245
    [No Abstract]   [Full Text] [Related]  

  • 6. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
    Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
    Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standards for clinical use of genetic variants.
    Nat Genet; 2014 Feb; 46(2):93. PubMed ID: 24473319
    [No Abstract]   [Full Text] [Related]  

  • 8. Exploring the landscape of pathogenic genetic variation in the ExAC population database: insights of relevance to variant classification.
    Song W; Gardner SA; Hovhannisyan H; Natalizio A; Weymouth KS; Chen W; Thibodeau I; Bogdanova E; Letovsky S; Willis A; Nagan N
    Genet Med; 2016 Aug; 18(8):850-4. PubMed ID: 26681313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family Studies for Classification of Variants of Uncertain Classification: Current Laboratory Clinical Practice and a New Web-Based Educational Tool.
    Garrett LT; Hickman N; Jacobson A; Bennett RL; Amendola LM; Rosenthal EA; Shirts BH
    J Genet Couns; 2016 Dec; 25(6):1146-1156. PubMed ID: 27422780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AACR Project GENIE: 100,000 Cases and Beyond.
    Pugh TJ; Bell JL; Bruce JP; Doherty GJ; Galvin M; Green MF; Hunter-Zinck H; Kumari P; Lenoue-Newton ML; Li MM; Lindsay J; Mazor T; Ovalle A; Sammut SJ; Schultz N; Yu TV; Sweeney SM; Bernard B;
    Cancer Discov; 2022 Sep; 12(9):2044-2057. PubMed ID: 35819403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huge Data-Sharing Project Launched.
    Rose S
    Cancer Discov; 2016 Jan; 6(1):4-5. PubMed ID: 26546297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
    Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
    Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
    Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
    JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine.
    Grellety T; Lucchesi C; Hostein I; Auzanneau C; Khalifa E; Soubeyran I; Italiano A
    Eur J Cancer; 2017 Oct; 84():250-256. PubMed ID: 28841542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Precision Medicine: Why More Is More and DNA Is Not Enough.
    Schütte M; Ogilvie LA; Rieke DT; Lange BMH; Yaspo ML; Lehrach H
    Public Health Genomics; 2017; 20(2):70-80. PubMed ID: 28595192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data.
    van Marcke C; Collard A; Vikkula M; Duhoux FP
    Crit Rev Oncol Hematol; 2018 Dec; 132():138-144. PubMed ID: 30447919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal.
    de Bruijn I; Kundra R; Mastrogiacomo B; Tran TN; Sikina L; Mazor T; Li X; Ochoa A; Zhao G; Lai B; Abeshouse A; Baiceanu D; Ciftci E; Dogrusoz U; Dufilie A; Erkoc Z; Garcia Lara E; Fu Z; Gross B; Haynes C; Heath A; Higgins D; Jagannathan P; Kalletla K; Kumari P; Lindsay J; Lisman A; Leenknegt B; Lukasse P; Madela D; Madupuri R; van Nierop P; Plantalech O; Quach J; Resnick AC; Rodenburg SYA; Satravada BA; Schaeffer F; Sheridan R; Singh J; Sirohi R; Sumer SO; van Hagen S; Wang A; Wilson M; Zhang H; Zhu K; Rusk N; Brown S; Lavery JA; Panageas KS; Rudolph JE; LeNoue-Newton ML; Warner JL; Guo X; Hunter-Zinck H; Yu TV; Pilai S; Nichols C; Gardos SM; Philip J; ; Kehl KL; Riely GJ; Schrag D; Lee J; Fiandalo MV; Sweeney SM; Pugh TJ; Sander C; Cerami E; Gao J; Schultz N
    Cancer Res; 2023 Dec; 83(23):3861-3867. PubMed ID: 37668528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
    Chen T; Wang Z; Zhou W; Chong Z; Meric-Bernstam F; Mills GB; Chen K
    BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):394. PubMed ID: 27356755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.